Ignite Creation Date:
2024-05-06 @ 3:58 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02418000
Status:
TERMINATED
Last Update Posted:
2019-03-20
First Post:
2015-02-18
Brief Title:
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 andor Ras Mutations
Sponsor:
Spirita Oncology LLC
Organization:
Spirita Oncology LLC
Organization Data
Organization:
Spirita Oncology LLC
Class:
INDUSTRY
Study ID:
BSC-101-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spirita Oncology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None